CompletedNCT04504253
Creatine Added to ECT for Major Depression
About this title
Read the official source — NCT04504253Placebo comparisonAges 18–99United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 99 years.
- Listed locations
- Salt Lake CitySee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateStarted: August 3, 2020
- Recruitment status
- Completed
- Enrollment listed in the registry
- 18
- Sponsor
- University of Utah
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Dietary supplement, Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 99 Years
- Official registry ID
- NCT04504253
- Official title
Show the full official title
A Pilot Study of Creatine Monohydrate as an Augmenting Agent for ECT in Persons With Major Depressive Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Salt Lake City
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Utah, a university.
Did this study involve medication?
Yes. The study involved medication, including Placebo.
Who was this study for?
Listed age limits: 18 years to 99 years.
